Skip to main content
OpenTrials
Completed

NCT Number: NCT04238897

To Evaluate the Efficacy and Safety of Aspherical Soft Contact Lens in Myopia Control

The objective of this study is to demonstrate that the Ticon Aspherical Daily Disposable Soft Contact Lens could retard myopia progress in youth

Completed

Looking for future studies?

Notify Me

Key information

Age range

9 year–15 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

This study is designed as a prospective, multicenter, randomized, double blinded, controlled, paired-eye comparison study. At least 60 evaluable subjects with myopia progression ≧ 0.75 D in the past 12 months will be recruited from 2 study sites. The experimental soft contact lens with aspherical design (Ticon Aspherical) will be randomly assigned to either the right eye or the left eye of the subject , then the fellow eye will be assigned a control lens with a single vision distance (SVD) soft contact lens (Ticon). Both lenses will be worn at least 8 hours a day, 5 days a week for 1 year. All lenses will be replaced every day. Brief assessment of the clinical findings will be followed up for one year at 1 day, 1 week, 1, 3, 6, 9, 12 months upon allocation. The primary efficacy outcome is change in spherical equivalent refraction (SER) measured by cycloplegic autorefraction over 12 months. The secondary outcome is change in axial eye length (AXL) measured over 12 months. The secondary outcome measure is used to corroborate any changes in SER

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Myopia (SE) between -1.00D to -8.00D
  • Astigmatism less than or equal to 1.75D
  • Myopia progression ≧0.75 D in the past 12 months
  • Best Corrected Visual Acuity (BCVA): 0.9 Snellen or better
  • Willingness to wear contact lens constantly
  • Availability for follow-up for at least 1 year
  • Parent's understanding and acceptance
  • have an acceptable surrogate capable of giving legally authorized consent on behalf of the subject

Exclusion criteria

  • Anisometropia greater than 2.00D
  • Presence of ocular disease preventing wear of contact lens
  • Severe ocular or systemic allergies
  • Taking any medication that might have an impact on contact lens wear or that might influence the outcome of the clinical trial
  • Ocular or systemic condition that might affect refractive development
  • Atropine/Pirenzepine treatment for myopia control in the past 1 month
  • Prior use of Ortho-K lenses
  • Dry eye with Schimer Test (basal secretion test) < 5mm/5min or other physical condition that would contraindicate contact lens wear

Treatment and study plan

Soft contact lens

Device

Primary outcomes

  1. Spherical Equivalent Refraction (SER)

    Time frame: 12 months

    The change in spherical equivalent refraction (SER) measured by cycloplegic autorefraction over 12 months.

Secondary outcomes

  1. Axial Eye Length (AXL)

    Time frame: 12 months

    The change in axial eye length (AXL) measured over 12 months. Axial length is measured after cycloplegia using optical biometry.

Other outcomes

  1. Primary safety Endpoints

    Time frame: 12 months

    All dispensed eyes over all follow-up visits. Measured on a scale of 0-4 with 0=no findings and 4=severe findings. Epithelial edema, epithelial microcysts, corneal staining, limbal & bulbar injection, conjunctival abnormalities, corneal neovascularization and infiltrates will be measured.

Sponsors and collaborators

Lead sponsor

APP Vision Care Inc.

Industry

Collaborators

  • National Taiwan University Hospital
  • Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Registry information

Official study title

A Prospective Randomized Control Study to Evaluate the Effect of Ticon Aspherical Daily Disposable Soft Contact Lens on Myopia Control

Important dates

Study start
2016
Primary completion
2018
Study completion
2019
First posted
Jan 23, 2020
Registry last updated
Jan 23, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.